Inhibitors of HIV proteinase
- 3 March 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (3), 273-286
- https://doi.org/10.1517/13543784.3.3.273
Abstract
This article briefly describes the identification of HIV proteinase as a potential target for antiviral chemotherapy, and discusses some of the strategies which have been used to discover inhibitors of this essential viral enzyme. Preclinical efficacy data are presented for selected inhibitors, and the ability of such compounds to generate a virus with reduced sensitivity is compared to that of reverse transcriptase inhibitors. The possibility of clinically useful synergistic interactions between inhibitors of HIV proteinase and other antiviral agents is also considered.Keywords
This publication has 50 references indexed in Scilit:
- Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidineAntimicrobial Agents and Chemotherapy, 1992
- Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse TranscriptaseScience, 1991
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Human Immunodeficiency Viruses and the Pathogenesis of AIDSPublished by American Medical Association (AMA) ,1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Genome organization and transactivation of the human immunodeficiency virus type 2Nature, 1987
- Molecular cloning and polymorphism of the human immune deficiency virus type 2Nature, 1986
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983